Christopher Galletta

CIK: 0001486099

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (33.3%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TRVI

Trevi Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

TRVI
Trevi Therapeutics, Inc.
Feb 19, 2026
Award(A)
Stock Option (right to buy)
Direct
35K shares-
TRVI
Trevi Therapeutics, Inc.
Dec 2, 2025
Exercise(M)
Direct
4.2K shares at avg. $0.51$2K
TRVI
Trevi Therapeutics, Inc.
May 31, 2025
Award(A)
Performance Stock Option (right to buy)
Direct
8.6K shares-
TRVI
Trevi Therapeutics, Inc.
Mar 10, 2025
Award(A)
Performance Stock Option (right to buy)
Direct
4.6K shares-
TRVI
Trevi Therapeutics, Inc.
Feb 18, 2025
Award(A)
Stock Option (right to buy)
Direct
41K shares-
TRVI
Trevi Therapeutics, Inc.
Dec 13, 2024
Exercise(M)
Direct
15K shares at avg. $0.51$8K

		Type	Shares	Price		Ownership
Feb 19, 2026	TRVI Trevi Therapeutics, Inc.	Award(A) Stock Option (right to buy)	35,000	-	-	Direct
Dec 2, 2025	TRVI Trevi Therapeutics, Inc.	Exercise(M)	4,225	$0.51	$2,159	Direct
May 31, 2025	TRVI Trevi Therapeutics, Inc.	Award(A) Performance Stock Option (right to buy)	8,550	-	-	Direct
Mar 10, 2025	TRVI Trevi Therapeutics, Inc.	Award(A) Performance Stock Option (right to buy)	4,560	-	-	Direct
Feb 18, 2025	TRVI Trevi Therapeutics, Inc.	Award(A) Stock Option (right to buy)	41,000	-	-	Direct
Dec 13, 2024	TRVI Trevi Therapeutics, Inc.	Exercise(M)	15,000	$0.51	$7,665	Direct

1-6 of 6 transactions

About Galletta Christopher

Galletta Christopher (SEC CIK 0001486099) files insider reports with the SEC as Officer of Trevi Therapeutics, Inc. (TRVI).

Signal8 holds 6 ownership filings by Galletta Christopher, all Form 4s, filed between Dec 17, 2024 and Feb 20, 2026. Those filings report 6 transactions, from Dec 13, 2024 to Feb 19, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Galletta Christopher's filings is in NEW HAVEN, CT.

Recent filings by Galletta Christopher

Feb 19, 2026: Grant or award of TRVI derivative securities (Form 4, code A).
Dec 2, 2025: Option exercise of TRVI shares (Form 4, code M).
May 31, 2025: Grant or award of TRVI derivative securities (Form 4, code A).
Mar 10, 2025: Grant or award of TRVI derivative securities (Form 4, code A).
Feb 18, 2025: Grant or award of TRVI derivative securities (Form 4, code A).

Other insiders filing for Trevi Therapeutics, Inc. (TRVI)

Heffernan Michael Thomas, Director
Mathers Edward T, Director
Colangelo Dominick, Director
Meeker David P, Director
VANLENT ANNE, Director
Cassella James V, Chief Development Officer

How to read Form 4 transaction codes